Form 4: Bio-Rad Laboratories CFO Receives Stock Grant
Insider Transaction (Form 4)
Roop Kalyan Lakkaraju, EVP, Chief Financial Officer of Bio-Rad Laboratories, Inc., reported multiple transactions in common stock on September 4, 2026.
Summary
- Option exercise/conversion: acquired 1,370 Bio-Rad A Common Stock on September 5, 2026; holds 3,956 after (Direct).
- Tax/exercise-price withholding: disposed of 559 Bio-Rad A Common Stock at $386.11 ($215,835) on September 5, 2026; holds 3,397 after (Direct).
- Option exercise/conversion: acquired 1,536 Bio-Rad A Common Stock on September 6, 2026; holds 4,933 after (Direct).
- Tax/exercise-price withholding: disposed of 782 Bio-Rad A Common Stock at $386.11 ($301,938) on September 6, 2026; holds 4,151 after (Direct).
- Grant/award: acquired 6,326 Restricted Stock Units on September 4, 2026; holds 6,326 after (Direct).
- Option exercise/conversion: disposed of 1,370 Restricted Stock Units on September 5, 2026; holds 4,110 after (Direct).
- Option exercise/conversion: disposed of 1,536 Restricted Stock Units on September 6, 2026; holds 3,072 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Roop Kalyan Lakkaraju — Officer (EVP, Chief Financial Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-05 | Option exercise/conversion | Bio-Rad A Common Stock | 1,370 | — | — | 3,955.963 |
| 2026-09-05 | Tax/exercise-price withholding | Bio-Rad A Common Stock | 559 | $386 | $215.8K | 3,396.963 |
| 2026-09-06 | Option exercise/conversion | Bio-Rad A Common Stock | 1,536 | — | — | 4,932.963 |
| 2026-09-06 | Tax/exercise-price withholding | Bio-Rad A Common Stock | 782 | $386 | $301.9K | 4,150.963 |
| 2026-09-04 | Grant/award | Restricted Stock Units | 6,326 | — | — | 6,326 |
| 2026-09-05 | Option exercise/conversion | Restricted Stock Units | 1,370 | — | — | 4,110 |
| 2026-09-06 | Option exercise/conversion | Restricted Stock Units | 1,536 | — | — | 3,072 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-05 | Option exercise/conversion (1,370 shares) |
| 2026-09-05 | Tax/exercise-price withholding (559 shares) |
| 2026-09-06 | Option exercise/conversion (1,536 shares) |
| 2026-09-06 | Tax/exercise-price withholding (782 shares) |
| 2026-09-04 | Grant/award (6,326 shares) |
| 2026-09-05 | Option exercise/conversion (1,370 shares) |
| 2026-09-06 | Option exercise/conversion (1,536 shares) |
Keywords
insider transaction, Form 4, BIO BIO.B, BIO-RAD LABORATORIES, INC., neutral, Roop Kalyan Lakkaraju
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.